首页|益气通心方联合达格列净治疗射血分数减低型心力衰竭临床研究

益气通心方联合达格列净治疗射血分数减低型心力衰竭临床研究

扫码查看
目的:观察益气通心方联合达格列净治疗射血分数减低型心力衰竭(heart failure with reduced ejection fraction,HFrEF)的临床疗效.方法:将120 例HFrEF患者随机分为对照组和观察组,每组各60 例.对照组给予达格列净,观察组给予益气通心方联合达格列净.比较两组患者的临床疗效、不良反应发生率及治疗前后中医证候积分变化情况,检测两组患者治疗前后炎性因子水平[超敏C反应蛋白(hypersensitive C-reactive protein,hs-CRP)、白细胞介素-6(interleukin-6,IL-6)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、脂蛋白相关磷脂酶A2(lipoprotein-associated phospholipase 2,Lp-PLA2)]及心功能指标[血清N末端B型钠尿肽前体(N-terminal brain natriuretic peptide,NT-proBNP)、生长刺激表达基因2 蛋白(growth stimulation expressed gene 2,ST2)、左室射血分数(left ventricular ejection fraction,LVEF)].结果:两组患者治疗后hs-CRP、IL-6、TNF-α、Lp-PLA2 及中医证候积分低于本组治疗前,且治疗后观察组低于对照组(P<0.05).两组患者治疗后NT-pro BNP、ST2 水平低于本组治疗前,LVEF水平高于本组治疗前,且治疗后组间比较,差异具有统计学意义(P<0.05).观察组有效率为86.67%,对照组有效率为70.00%,差异具有统计学意义(P<0.05).观察组不良反应发生率低于对照组,但差异无统计学意义(P>0.05).结论:益气通心方联合达格列净治疗射血分数减低型心力衰竭,可缓解患者的临床症状,降低炎性因子水平,改善心功能指标,提高临床疗效,且不良反应较少.
Clinical Study on Qi-Replenishing and Heart-Dredging Decoction Combined with Dapagliflozin in the Treatment of Heart Failure with Reduced Ejection Fraction
Objective:To observe the clinical efficacy of Qi-Replenishing and Heart-Dredging Decoction combined with Dapagliflozin on heart failure with reduced ejection fraction(HFrEF).Methods:A total of 120 HFrEF patients were randomly divided into the control group and the observation group,with 60 cases in each group.The control group was given Dapagliflozin,while the observation group was given a combination of Qi-Replenishing and Heart-Dredging Decoction and Dapagliflozin.The clinical efficacy,incidence of adverse re-actions,and changes in TCM syndrome scores before and after treatment were compared between the two groups.The levels of inflamma-tory factors[including hypersensitive C-reactive protein(hs-CRP),interleukin-6(IL-6),tumor necrosis factor alpha(TNF-α),lipo-protein associated phospholipase 2(Lp-PLA2)],and cardiac function indicators[including serum N-terminal brain natriuretic peptide precursor(NT-proBNP),growth stimulation expressed gene 2(ST2),and left ventricular ejection fraction(LVEF)]were detected.Results:After treatment,hs-CRP,IL-6、TNF-α,Lp-PLA2 and TCM syndrome scores were lower than those before treatment in each group,and the observation group's above indicators were lower than those of the control group(P<0.05).The levels of NT-pro BNP and ST2 in the two groups were lower than those before treatment,while the level of LVEF was higher than that before treatment.All the differences between the two groups were statistically significant(P<0.05).The effective rate of the observation group was86.67%,while that of the control group was70.00%,with a statistically significant difference(P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,but the difference was not statistically significant(P>0.05).Conclu-sion:The combination of Qi-Replenishing and Heart-Dredging Decoction and Dapagliflozin in the treatment of heart failure with reduced ejection fraction can alleviate clinical symptoms,reduce inflammatory factor levels,improve cardiac function indicators,and enhance clinical efficacy without significant adverse reactions.

heart failure reduced ejection fractionQi-Replenishing and Heart-Dredging DecoctionDapagliflozinintegrated traditional Chinese and Western medicine therapy

王俊涛

展开 >

汝南县中医院,河南 汝南 463300

射血分数减低型心力衰竭 益气通心方 达格列净 中西医结合疗法

2024

河南中医
河南省中医药学会 河南中医学院

河南中医

影响因子:0.968
ISSN:1003-5028
年,卷(期):2024.44(10)